middle.news
Resonance Health Accelerates Growth with Record Cashflow and Major Clinical Trials
6:12am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Resonance Health Accelerates Growth with Record Cashflow and Major Clinical Trials
6:12am on Monday 2nd of June, 2025 AEST
Key Points
Record $14.9M cash receipts and $3.1M positive operating cashflow over last 12 months
Completed cost efficiency program cutting 12 roles, saving $1.1M annually
Two major global pharma clinical trials progressing with $8M invoiced and $12M remaining
SaMD business secured contract extensions worth over $1M and strong $2.5M-$3M pipeline
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resonance Health (ASX:RHT)
OPEN ARTICLE